These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 6871919

  • 21. [Aprindine treatment of ventricular arrhythmias].
    Sellier P.
    Coeur Med Interne; 1980; 19(1):67-71. PubMed ID: 7379481
    [No Abstract] [Full Text] [Related]

  • 22. Effect of aprindine on transmembrane currents and contractile force in frog atria.
    Gilmour RF, Chikharev VN, Jurevichus JA, Zacharov SI, Zipes DP, Rosenshtraukh LV.
    J Pharmacol Exp Ther; 1981 May; 217(2):390-6. PubMed ID: 7229981
    [Abstract] [Full Text] [Related]

  • 23. Prospective echocardiographic assessment of androgenic-anabolic steroids effects on cardiac structure and function in strength athletes.
    Hartgens F, Cheriex EC, Kuipers H.
    Int J Sports Med; 2003 Jul; 24(5):344-51. PubMed ID: 12868045
    [Abstract] [Full Text] [Related]

  • 24. Chronic administration of aprindine during maintenance hemodialysis.
    Takata Y, Tsuchihashi T, Nakamura S, Hirota Y.
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):553-6. PubMed ID: 9455712
    [Abstract] [Full Text] [Related]

  • 25. [Comparison of the efficacy of aprindine and quinidine in chronic ventricular rhythm disorders].
    Leclercq JF, Attuel P, Milosevic D, Rosengarten MD, Coumel P.
    Arch Mal Coeur Vaiss; 1981 Aug; 74(8):923-30. PubMed ID: 6793009
    [Abstract] [Full Text] [Related]

  • 26. [Dilated myocardiopathies: the relationship between the degree of cardiac dysfunction and ventricular arrhythmias. A clinical follow-up].
    Abreu A, Pereira H, Catarino C, Branco L, Valério L, Nunes H, Gonçalves JM, Gracias R, Antunes AM.
    Rev Port Cardiol; 1993 Jan; 12(1):8, 33-7. PubMed ID: 8517976
    [Abstract] [Full Text] [Related]

  • 27. Electrophysiology and pharmacology of aprindine, encainide, and propafenone.
    Zipes DP, Prystowsky EN, Heger JJ.
    Ann N Y Acad Sci; 1984 Jan; 432():201-9. PubMed ID: 6441495
    [No Abstract] [Full Text] [Related]

  • 28. Antiarrhythmic effect of aprindine on several types of ventricular arrhythmias.
    Ueda M, Kimoto S, Matsuda S, Kawakami M, Mroishige E, Matsumura S, Takeda H.
    Jpn J Pharmacol; 1975 Oct; 25(5):549-61. PubMed ID: 1221137
    [Abstract] [Full Text] [Related]

  • 29. [Aprindine, an anti-arrhythmia agent for arrhythmia associated with myocardial infarct].
    Ikeda T, Kubota K, Higashino A, Hattori N.
    Nihon Rinsho; 1983 Dec; 41(12):2760-5. PubMed ID: 6674561
    [No Abstract] [Full Text] [Related]

  • 30. Electrophysiological effects of aprindine on A-V conduction in the dog.
    Ferrero Cabedo JA, Insa Pérez LD, López Merino V, Botella Solana S, Brugger Auban A, Esplugues Requena J.
    Arch Int Pharmacodyn Ther; 1978 Nov; 236(1):154-63. PubMed ID: 747461
    [No Abstract] [Full Text] [Related]

  • 31. Rationale and design of the hemodynamic, echocardiographic and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure (HORIZON-HF) trial.
    Blair JE, Macarie C, Ruzyllo W, Bacchieri A, Valentini G, Bianchetti M, Pang PS, Harinstein ME, Sabbah HN, Filippatos GS, Gheorghiade M, HORIZON-HF investigators.
    Am J Ther; 2008 Nov; 15(3):231-40. PubMed ID: 18496261
    [Abstract] [Full Text] [Related]

  • 32. Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers.
    Mercuro G, Cadeddu C, Piras A, Dessì M, Madeddu C, Deidda M, Serpe R, Massa E, Mantovani G.
    Oncologist; 2007 Sep; 12(9):1124-33. PubMed ID: 17914082
    [Abstract] [Full Text] [Related]

  • 33. Diastolic function impairment in alcoholics.
    Fernández-Solà J, Nicolás JM, Paré JC, Sacanella E, Fatjó F, Cofán M, Estruch R.
    Alcohol Clin Exp Res; 2000 Dec; 24(12):1830-5. PubMed ID: 11141042
    [Abstract] [Full Text] [Related]

  • 34. [Non invasive quantification of the parietal systolic stress of the left ventricle in patients with heart failure and its clinical application].
    Guadalajara Boo JF, González Zárate J, Bucio Reta E, Pérez P, Cué Carpio RJ.
    Arch Cardiol Mex; 2007 Dec; 77(2):120-9. PubMed ID: 17715625
    [Abstract] [Full Text] [Related]

  • 35. Alterations in regional myocardial distribution and arrhythmogenic effects of aprindine produced by coronary artery occlusion in the dog.
    Nattel S, Pedersen DH, Zipes DP.
    Cardiovasc Res; 1981 Feb; 15(2):80-5. PubMed ID: 7260980
    [Abstract] [Full Text] [Related]

  • 36. Agranulocytosis associated with aprindine therapy.
    Bodenheimer HC, Samarel AM.
    Arch Intern Med; 1979 Oct; 139(10):1181-2. PubMed ID: 485754
    [Abstract] [Full Text] [Related]

  • 37. [Clinical evaluation of a new drug (Aprindine) on ventricular and superventricular arrhythmia].
    Villalobos Galán E, Martin Santos F, Fernández Corral E, de Elio Membrado FJ.
    Rev Clin Esp; 1975 Sep 15; 138(5):461-8. PubMed ID: 1178995
    [No Abstract] [Full Text] [Related]

  • 38. Studies with aprindine.
    Zipes DP, Elharrar V, Gilmour RF, Heger JJ, Prystowsky EN.
    Am Heart J; 1980 Dec 15; 100(6 Pt 2):1055-62. PubMed ID: 6255785
    [Abstract] [Full Text] [Related]

  • 39. Arrhythmia indicators.
    Check WA.
    Arch Intern Med; 1979 Oct 15; 139(10):1079. PubMed ID: 485733
    [No Abstract] [Full Text] [Related]

  • 40. [Aprindine for intractable dysarrhythmia (author's transl)].
    Fang WH.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1980 Sep 15; 8(3):210-2. PubMed ID: 7307950
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.